Literature DB >> 35064852

Periods of Homelessness Linked to Higher VACS Index Among HIV-Positive People Who Use Drugs.

Hudson Reddon1,2, M Eugenia Socias1,2, Amy Justice3,4, Zishan Cui1,2, Ekaterina Nosova1, Rolando Barrios5, Nadia Fairbairn1,2, Brandon D L Marshall6, M-J Milloy7,8.   

Abstract

We sought to evaluate the impact of homelessness on HIV disease progression among people who use unregulated drugs (PWUD) living with HIV and test if this association was mediated by adherence to antiretroviral therapy (ART). We applied general linear mixed-effects modeling to estimate the longitudinal relationship between homelessness and the Veterans Aging Cohort Study (VACS) Index, a validated measure of HIV disease progression that predicts all-cause mortality, among a prospective cohort of PWUD. In a longitudinal model adjusted for ART adherence, homelessness was significantly associated with increased VACS Index scores and 16% of the association was mediated by ART adherence. These findings indicate that homelessness was a significant risk factor for HIV disease progression and this association was marginally mediated by ART adherence. Future studies are needed to quantify the other mechanisms (e.g., food insecurity, mental health) by which homelessness increases mortality risk among PWUD living with HIV.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Antiretroviral therapy; HIV; Homelessness; Mortality; VACS Index

Mesh:

Year:  2022        PMID: 35064852      PMCID: PMC9150923          DOI: 10.1007/s10461-021-03524-1

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  83 in total

1.  Factors associated with the health care utilization of homeless persons.

Authors:  M B Kushel; E Vittinghoff; J S Haas
Journal:  JAMA       Date:  2001-01-10       Impact factor: 56.272

2.  Needle exchange is not enough: lessons from the Vancouver injecting drug use study.

Authors:  S A Strathdee; D M Patrick; S L Currie; P G Cornelisse; M L Rekart; J S Montaner; M T Schechter; M V O'Shaughnessy
Journal:  AIDS       Date:  1997-07       Impact factor: 4.177

3.  Social and structural factors associated with greater time with a plasma HIV-1 RNA viral load above log10(1500) copies/ml among illicit drug users.

Authors:  Mary Clare Kennedy; Thomas H Kerr; Evan Wood; Jeannie A Shoveller; Julio S G Montaner; M-J S Milloy
Journal:  AIDS       Date:  2018-05-15       Impact factor: 4.177

4.  Social and environmental predictors of plasma HIV RNA rebound among injection drug users treated with antiretroviral therapy.

Authors:  M-J Milloy; Thomas Kerr; Jane Buxton; Tim Rhodes; Andrea Krusi; Silvia Guillemi; Robert Hogg; Julio Montaner; Evan Wood
Journal:  J Acquir Immune Defic Syndr       Date:  2012-04-01       Impact factor: 3.731

5.  The effect of different meal types on the pharmacokinetics of darunavir (TMC114)/ritonavir in HIV-negative healthy volunteers.

Authors:  Vanitha Sekar; Dries Kestens; Sabrina Spinosa-Guzman; Martine De Pauw; Els De Paepe; Tony Vangeneugden; Eric Lefebvre; Richard M W Hoetelmans
Journal:  J Clin Pharmacol       Date:  2007-04       Impact factor: 3.126

6.  Sleep deprivation in an American homeless population.

Authors:  Ariana Gonzalez; Quinn Tyminski
Journal:  Sleep Health       Date:  2020-02-13

7.  Incidence and predictors of mental health disorder diagnoses among people who inject drugs in a Canadian setting.

Authors:  Hudson Reddon; Tyler Pettes; Evan Wood; Ekaterina Nosova; Michael-John Milloy; Thomas Kerr; Kanna Hayashi
Journal:  Drug Alcohol Rev       Date:  2017-11-22

8.  The association between food insecurity and mortality among HIV-infected individuals on HAART.

Authors:  Sheri D Weiser; Kimberly A Fernandes; Eirikka K Brandson; Viviane D Lima; Aranka Anema; David R Bangsberg; Julio S Montaner; Robert S Hogg
Journal:  J Acquir Immune Defic Syndr       Date:  2009-11-01       Impact factor: 3.731

9.  Oral cannabinoids in people living with HIV on effective antiretroviral therapy: CTN PT028-study protocol for a pilot randomised trial to assess safety, tolerability and effect on immune activation.

Authors:  Cecilia T Costiniuk; Zahra Saneei; Jean-Pierre Routy; Shari Margolese; Enrico Mandarino; Joel Singer; Bertrand Lebouché; Joseph Cox; Jason Szabo; Marie-Josée Brouillette; Marina B Klein; Nicolas Chomont; Mohammad-Ali Jenabian
Journal:  BMJ Open       Date:  2019-01-17       Impact factor: 2.692

Review 10.  Morbidity and mortality in homeless individuals, prisoners, sex workers, and individuals with substance use disorders in high-income countries: a systematic review and meta-analysis.

Authors:  Robert W Aldridge; Alistair Story; Stephen W Hwang; Merete Nordentoft; Serena A Luchenski; Greg Hartwell; Emily J Tweed; Dan Lewer; Srinivasa Vittal Katikireddi; Andrew C Hayward
Journal:  Lancet       Date:  2017-11-12       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.